TrialJAMA ophthalmology2020

Outcomes of Vismodegib for Periocular Locally Advanced Basal Cell Carcinoma From an Open-label Trial.

Meydan Ben Ishai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.